Jazz Pharmaceuticals plc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Material agreementSep 23 →InsidersNo open-market buys. 10 insiders sold $43.5M, 12 of 46 sales on a 10b5-1 plan.→Financing →PeersClosest companies: PARA, BLFS, ANAB→
From the filings
Figures
- Revenue
- $4.60Blast 12 months
- Net income
- $940.8Mlast 12 months
- Operating cash flow
- $1.33Blast 12 months
- Cash and equivalents
- $1.62Bat the last balance sheet
- Total debt
- $4.35Bat the last balance sheet
- Shares outstanding
- 61.4M shareson issue